Search results
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 15 hours agoPfizer PFE reported first-quarter 2024 adjusted earnings per share of 82 cents, which comfortably...
Pfizer hemophilia gene therapy arrives in US to uncertain future
BioPharma Dive via Yahoo Finance· 6 days agoDive Brief: The Food and Drug Administration on Friday approved a new gene therapy for hemophilia,...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 19 hours agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Market Watch· 20 hours agoAn expected drop in COVID-19-related product sales, including antiviral Paxlovid and vaccine...
Pfizer Q1 earnings: non-Covid product sales help post revenues of $14.9 billion despite Comirnaty,...
Invezz· 20 hours agoPfizer Inc. has announced its financial outcomes for the first quarter of 2024, displaying strong...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 1 day agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...
Pfizer reports dip in first quarter profits, yet beats estimates
dpa international via Yahoo Finance· 15 hours agoThe US pharmaceutical giant Pfizer on Wednesday said its earnings for the first quarter had declined...
Pfizer: Q1 Earnings Snapshot
Midland Reporter-Telegram· 20 hours agoNEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Wednesday reported first-quarter...
Pfizer Stock Rises as Outlook Raised After Earnings Beat
Barrons.com· 20 hours agoPfizer reports first-quarter adjusted earnings of 82 cents a share on revenue of $14.88 billion.Read...
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
FierceBiotech· 13 hours agoPfizer’s 2024 revival tour is off and running, but the Big Pharma remains mum on one critical...